Email Updates

Search form

You are here

3 November 2017 VOLUME 18 ISSUE 44

Media Coverage

  • A mobile app is being developed to help prevent HIV among transgender women by connecting them with supportive peers anytime and anyplace. Called Transwoman Connected, the app is being created by California-based dfusion in partnership with Portland State University and support from a National Institutes of Health grant.

    November 3, 2017
    POZ
  • Human rights groups and activists who converged in Lilongwe recently for the media advocacy meeting on HIV and Aids Bill described the new bill on HIV and AIDS as a debauched law in the offing…. Mandatory HIV testing and the disclosure of medical information without consent are contrary to international best practices and violate fundamental human rights, the rights activists said.

    November 2, 2017
    General
    Nyasa Times
  • Gilead Sciences and GlaxoSmithKline are heading for an HIV showdown, pushing rival treatment visions and competing products that are expected to hit the market in the next few months. Gilead is likely to secure the bigger near-term win…while GSK is placing a longer bet that its core drug is potent enough to work with just one other.

    November 2, 2017
    Reuters
  • The San Francisco Department of Public Health has launched a campaign to close the information gap about the drug, and held a briefing for ethnic media where Barajas, Wilder, and other advocates spoke.

    November 2, 2017
    New America Media
  • A study of men who have sex with men (MSM) conducted by the European Centre for Disease Prevention and Control (ECDC) in collaboration with the gay contact site Hornet has found that pre-exposure prophylaxis (PrEP) usage has not increased, on average, among its respondents over the proportion reported last year, when a similar survey was carried out.

    November 1, 2017
    aidsmap
  • I am proud to announce the theme for World AIDS Day 2017: Increasing Impact Through Transparency, Accountability, and Partnerships. This theme reflects the United States government’s longstanding leadership in addressing HIV/AIDS both at home and abroad and how we are increasing our impact to move epidemics from crisis toward control.

    November 1, 2017
    General
    Huffington Post
  • ViiV Healthcare reported the discovery of a new experimental HIV attachment inhibitor that was effective in treating people with “highly drug-resistant HIV.” In the BRIGHTE Phase 3 study (in which ViiV was a participating partner), researchers found that a drug called fostemsavir was able to control the viral load in about half the study’s participants

    November 1, 2017
    HIV Plus Mag
  • United Nations Children’s Fund (UNICEF), has said that about 80 per cent of the HIV transmission in Nigeria happens through sexual intercourse… about 10% of infections is through blood transfusion, while the other 10% is through other routes such as Mother to Child Transmission (MTCT), Injection Drug User (IDU), use of unsterilized instruments etc.

    November 1, 2017
    General
    New Nigerian
  • The words people use to talk about HIV affect the way people living with HIV feel about themselves. These words also have an impact on how others perceive people living with HIV.

    October 31, 2017
    General
    Body
  • Hepatitis C incidence is increasing among gay and bisexual men living with HIV in San Diego, according to the largest analysis of its kind done in the United States. Study results were presented last week at the 2017 AASLD Liver Meeting in Washington, DC.

    October 31, 2017
    General
    HIV and Hepatitis
  • A simple pill taken once a day and used in the US and Europe has shown encouraging results in stopping the spread of HIV, and AIDS-Fundet, the Danish AIDS organisation, would like to see it used in Denmark.

    October 30, 2017
    CPH Post Online
  • Advocates have been fighting the Trump administration tooth and nail to preserve HIV/AIDS funding. So far, they've been largely successful—but experts say any lapse in budget could be a huge setback.

    October 30, 2017
    General
    VICE
  • One piece of a future vaccine for HIV might be falling into place, as researchers announced they found a way to target molecules that protect the virus from the body’s immune system.

    October 30, 2017
    Antibody Related Research, HIV Vaccine
    IB Times
  • Fostemsavir, a new experimental attachment inhibitor, suppressed viral load in over half of participants with extensive drug resistance when added to a background regimen selected by resistance testing...

    October 28, 2017
    aidsmap
  • Canada's new feminist foreign aid policy provides hope…. Donor countries are increasingly and publicly focusing on women first as they set their priorities…. We now need more countries like Canada to join in reducing the inequities that women face in public health crises like HIV.

    October 27, 2017
    General
    Huffington Post
  • At least 18 clinics and hospitals in Limpopo are without HIV testing kits as months-long shortages of the HIV diagnostics continue in the province, say activists from Aids lobby group the Treatment Action Campaign (TAC). TAC provincial chairperson Moses Makhomisane says he fears rape survivors might miss out on preventative treatment because of the shortage of HIV testing kits.

    October 3, 2017
    Bhekisisa

Published Research

Announcements

  • Even close readers of the Weekly NewsDigest may be surprised to know that we are closing in on 18 years of weekly updates. Much has changed over these years – the HIV prevention news itself, the media world, and the technologies that help us compile and edit each issue. But there has always been one constant – the remarkable Polly Harrison!

    November 3, 2017
    General
    AVAC